An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Trial Profile

An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Denosumab (Primary)
  • Indications Bone metastases; Breast cancer; Cancer; Cancer metastases; Multiple myeloma; Prostate cancer
  • Focus Adverse reactions
  • Sponsors Amgen
  • Most Recent Events

    • 19 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 11 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top